Lv41
588 积分 2025-08-07 加入
Hijacking ERAD for targeted degradation of transmembrane proteins
1天前
已完结
Hijacking ERAD for targeted degradation of transmembrane proteins
4天前
已完结
Discovery of (S)-6-methoxy-chroman-3-carboxylic acid (4-pyridin-4-yl-phenyl)-amide as potent and isoform selective ROCK2 inhibitors
17天前
已完结
Rational Design of 6‐Amino‐2‐Piperazinylpyridine‐Based ROCK2 Inhibitors With Anti‐Breast Cancer Metastatic Efficiency
18天前
已完结
Rational Design of 6‐Amino‐2‐Piperazinylpyridine‐Based ROCK2 Inhibitors With Anti‐Breast Cancer Metastatic Efficiency
20天前
已完结
Design and optimization strategies of PROTACs and its Application, Comparisons to other targeted protein degradation for multiple oncology therapies
1个月前
已完结
ROCK-2-selective targeting and its therapeutic outcomes
1个月前
已完结
Rho/ROCK Pathway as a Therapeutic Target in Multiple Diseases
1个月前
已完结
Complete biosynthesis of the anticancer cephalotaxinone and homoerythratine
1个月前
已完结
Targeted Degradation of Capsid by Host-Hijacking PROTAC Overcomes Drug Resistance
1个月前
已完结
皖公网安备34019202002308
